We use cookies to so our web site can function correctly. By Clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed. To find out more visit the cookies section of our privacy policy.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Vesna-Pavasovic-Malignant-Paediatric-Haematology

Dr Vesna Pavasovic

MD, FRCPCH

Consultant in Malignant Paediatric Haematology and Late Effects in Childhood Cancer Survivors

Fixed Price Packages

About

  • Biography icon plus

    Since early 2015, Dr Pavasovic has been working as the Consultant in Malignant Paediatric Haematology with special interest in Non-Hodgkins Lymphoma, Leukaemia and Late Effects in Childhood Cancer Survivors in London.
    Since 2016, she is a Lead of Late Effect in Childhood Cancer Survivors Service within the largest Paediatric Late Effects Service in the UK with a flow of nearly 1000 patients per year. She is one of the co-developers of the First UK OncoFertility Consortium, a programme with the goal to improve fertility outcomes in young patients diagnosed with cancer. In 2016 she became Member of PanCare Network and since 2017 is acting as PanCare Board Member. She is a member of the International Guideline Harmonization Group with a focus on Renal and Bone Health Surveillance.

    In Research Portfolio: She is Principal Investigator in International Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor) in London, UK (Servier; 2017-2032). She is Co- Investigator in Grant proposal for collection of retrospective data on Secondary Cancers and Long Term Adverse Outcomes in Acute Lymphoblastic Leukaemia Survivors treated on UK Trials since 1970. She is Co-Investigator in ""Pain experience and somatosensory function in survivors of paediatric haematological malignancies: A cross-sectional cohort study in late adolescence"" is a collaboration between members of the Paediatric Pain Research Group and Haematology/BMT Late Effects Clinic. Within National Renal Group she has completed work on UK data on Relapse Wilms Tumour assigned to UKWR Study. The available data on outcome and prognostic variables in relapsed Wilms’ tumour have been used to define treatment groups for this protocol and to develop a therapeutic strategy that will hopefully improve overall outcome.

  • Clinical interests icon plus

    Lymphoma and Late Effects in Childhood Cancer Survivors. 
     

Practice locations

NHS base

Great Ormond Street Hospital For Children

back to top